IL-17 is able to promote tumor angiogenesis (Numasaki et al., 2003) by inducing the expression of vascular endothelial growth factor (VEGF), which acts as a pathogenic role in CRC formation (Li et al., 2019a). This evidence concerns the gene IL17A and neoplasm.